CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | 1-naphthyl isothiocyanate |
|
Accession: | CHEBI:35455
|
browse the term
|
Definition: | An isothiocyanate that has formula C11H7NS. |
Synonyms: | exact_synonym: | 1-isothiocyanatonaphthalene |
| related_synonym: | 1-Naphthylisothiocyanate; ANIT; Formula=C11H7NS; InChI=1S/C11H7NS/c13-8-12-11-7-3-5-9-4-1-2-6-10(9)11/h1-7H; InChIKey=JBDOSUUXMYMWQH-UHFFFAOYSA-N; SMILES=S=C=Nc1cccc2ccccc12; alpha-Naphthyl isothiocyanate |
| xref: | Beilstein:637868; CAS:551-06-4 |
| xref_mesh: | MESH:D015058 |
|
|
|
G |
A2m |
alpha-2-macroglobulin |
affects expression increases expression |
EXP |
1-Naphthylisothiocyanate affects the expression of A2M mRNA 1-Naphthylisothiocyanate results in increased expression of A2M mRNA |
CTD |
PMID:12883083 PMID:18289764 PMID:25380136 |
|
NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
|
|
G |
A3galt2 |
alpha 1,3-galactosyltransferase 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of A3GALT2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:146,933,592...146,945,882
Ensembl chr 5:146,933,592...146,945,880
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AACS mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:36,512,393...36,555,694
Ensembl chr12:36,512,393...36,555,694
|
|
G |
Aadac |
arylacetamide deacetylase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AADAC mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:150,146,234...150,157,480
Ensembl chr 2:150,146,234...150,157,480
|
|
G |
Aadat |
aminoadipate aminotransferase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AADAT mRNA |
CTD |
PMID:25380136 |
|
NCBI chr16:32,832,001...32,868,680
Ensembl chr16:32,832,061...32,868,702
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ABAT mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:7,093,406...7,200,439
Ensembl chr10:7,093,405...7,200,499
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions decreases expression increases expression |
ISO EXP |
18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of ABCB11 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB11 mRNA; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein] 1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA; 1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein 1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCB11 protein dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCB11 mRNA |
CTD |
PMID:17522070 PMID:19181614 PMID:19407337 PMID:24120425 PMID:25418378 PMID:25655198 PMID:27317372 PMID:27344345 PMID:27702592 PMID:27765674 PMID:27853831 PMID:28549656 PMID:29660435 PMID:29968724 PMID:30352267 PMID:30517764 PMID:32198087 PMID:32579994 |
|
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression affects expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of ABCB1 mRNA 1-Naphthylisothiocyanate affects the expression of ABCB1A mRNA [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB1A mRNA |
CTD |
PMID:17522070 PMID:30352267 PMID:30723492 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions decreases expression increases expression |
ISO EXP |
18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of ABCB4 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB4 mRNA; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 protein]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]] 1-Naphthylisothiocyanate results in decreased expression of ABCB4 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCB4 mRNA 1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCB4 protein |
CTD |
PMID:14623915 PMID:15913567 PMID:19181614 PMID:19407337 PMID:25655198 PMID:27344345 PMID:27765674 PMID:28549656 PMID:29968724 PMID:30352267 |
|
NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression multiple interactions decreases expression |
ISO |
1-Naphthylisothiocyanate results in increased expression of ABCC1 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC1 mRNA] |
CTD |
PMID:15913567 PMID:28549656 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases response to substance decreases expression increases expression multiple interactions |
ISO EXP |
ABCC2 results in increased susceptibility to 1-Naphthylisothiocyanate 1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA; 1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein 1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCC2 protein dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein] alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; NR1H4 promotes the reaction [obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein] |
CTD |
PMID:20551477 PMID:25380136 PMID:25418378 PMID:25655198 PMID:26365562 PMID:27317372 PMID:27702592 PMID:27765674 PMID:29660435 PMID:30517764 PMID:32198087 PMID:32579994 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions decreases expression affects expression increases expression |
ISO EXP |
18alpha-glycyrrhetinic acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ABCC3 mRNA]; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCC3 mRNA; Glycyrrhizic Acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ABCC3 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 protein] 1-Naphthylisothiocyanate results in decreased expression of ABCC3 mRNA resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 protein] 1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCC3 protein |
CTD |
PMID:14623915 PMID:17522070 PMID:19181614 PMID:19407337 PMID:25418378 PMID:25655198 PMID:26365562 PMID:27765674 PMID:28549656 PMID:30352267 PMID:30517764 PMID:30723492 PMID:32579994 |
|
NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
decreases expression increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in decreased expression of ABCC4 mRNA 1-Naphthylisothiocyanate results in increased expression of ABCC4 mRNA [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCC4 mRNA; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC4 mRNA] |
CTD |
PMID:27765674 PMID:30352267 PMID:30517764 |
|
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ABCC8 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:102,110,708...102,191,287
Ensembl chr 1:102,110,708...102,191,287
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ABCG1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr20:9,743,269...9,842,735
Ensembl chr20:9,743,269...9,840,489
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression multiple interactions increases expression |
EXP ISO |
1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA] 1-Naphthylisothiocyanate results in increased expression of ABCG5 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCG5 mRNA |
CTD |
PMID:25380136 PMID:27344345 PMID:27765674 PMID:28549656 PMID:30723492 |
|
NCBI chr 6:7,935,771...7,961,207
Ensembl chr 6:7,935,771...7,961,207
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in decreased expression of ABCG8 mRNA 1-Naphthylisothiocyanate results in increased expression of ABCG8 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCG8 mRNA |
CTD |
PMID:25380136 PMID:27344345 PMID:27765674 PMID:30723492 |
|
NCBI chr 6:7,961,413...7,980,708
Ensembl chr 6:7,961,413...7,980,708
|
|
G |
Abhd11-as1 |
ABHD11 antisense RNA 1 (tail to tail) |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ABHD11OS mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:24,721,190...24,722,177
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ABLIM3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr18:57,126,534...57,245,965
Ensembl chr18:57,128,399...57,245,666
|
|
G |
Abtb2 |
ankyrin repeat and BTB domain containing 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ABTB2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:93,494,706...93,648,750
Ensembl chr 3:93,495,106...93,647,721
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACACA mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:71,519,392...71,719,910
Ensembl chr10:71,536,533...71,719,910
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACACB mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:48,127,149...48,238,969
Ensembl chr12:48,127,149...48,238,887
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACADM mRNA |
CTD |
PMID:17522070 |
|
NCBI chr 2:260,124,418...260,148,589
Ensembl chr 2:260,124,418...260,148,589
|
|
G |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACAP1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:56,492,300...56,506,446
Ensembl chr10:56,492,300...56,506,446
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACAT1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
affects expression increases expression multiple interactions |
ISO EXP |
1-Naphthylisothiocyanate affects the expression of ACAT2 mRNA 1-Naphthylisothiocyanate results in increased expression of ACAT2 mRNA 18alpha-glycyrrhetinic acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ACAT2 mRNA]; Glycyrrhizic Acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ACAT2 mRNA] |
CTD |
PMID:28549656 PMID:30723492 |
|
NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
|
|
G |
Acat2l1 |
acetyl-CoA acetyltransferase 2-like 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACAT2L1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:48,008,574...48,025,730
Ensembl chr 1:47,996,521...48,026,268
|
|
G |
Acbd4 |
acyl-CoA binding domain containing 4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACBD4 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:91,186,131...91,200,081
Ensembl chr10:91,187,593...91,196,572
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACKR3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 9:97,355,881...97,367,455
Ensembl chr 9:97,355,924...97,367,445
|
|
G |
Acly |
ATP citrate lyase |
decreases expression increases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACLY mRNA 1-Naphthylisothiocyanate results in increased expression of ACLY mRNA |
CTD |
PMID:17522070 PMID:30723492 |
|
NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
|
|
G |
Acod1 |
aconitate decarboxylase 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACOD1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:93,612,968...93,622,322
Ensembl chr15:93,612,971...93,622,358
|
|
G |
Acot12 |
acyl-CoA thioesterase 12 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACOT12 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:20,857,056...20,901,656
Ensembl chr 2:20,857,202...20,901,659
|
|
G |
Acot3 |
acyl-CoA thioesterase 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACOT3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:107,531,508...107,537,446
Ensembl chr 6:107,531,528...107,536,789
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACOX1 mRNA |
CTD |
PMID:12883083 |
|
NCBI chr10:104,724,534...104,748,003
Ensembl chr10:104,722,958...104,748,050
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACOX2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr15:18,449,304...18,481,472
Ensembl chr15:18,451,144...18,481,470
|
|
G |
Acp3 |
acid phosphatase 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACP3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:112,838,574...112,884,062
Ensembl chr 8:112,834,707...112,884,077
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACP5 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:23,142,733...23,149,067
Ensembl chr 8:23,142,734...23,148,396
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACSL1 mRNA |
CTD |
PMID:17522070 PMID:25380136 PMID:30723492 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACSL3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:84,569,601...84,593,565
Ensembl chr 9:84,569,597...84,593,565
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ACSM3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:189,514,504...189,541,233
Ensembl chr 1:189,514,553...189,541,224
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACSS2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACTA1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:56,674,072...56,677,084
Ensembl chr19:56,674,074...56,677,084
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACTA2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Actg1 |
actin, gamma 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACTG1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:109,518,429...109,521,288
Ensembl chr 3:75,643,054...75,644,954 Ensembl chr10:75,643,054...75,644,954
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACTN1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555
|
|
G |
Actn3 |
actinin alpha 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ACTN3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:220,120,532...220,136,460
Ensembl chr 1:220,120,533...220,136,470
|
|
G |
Ada |
adenosine deaminase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADA mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ADAM8 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADAMTS7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:97,535,777...97,575,661
Ensembl chr 8:97,535,777...97,575,655
|
|
G |
Adcy10 |
adenylate cyclase 10 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADCY10 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:83,701,952...83,787,010
Ensembl chr13:83,721,300...83,787,018
|
|
G |
Add2 |
adducin 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADD2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:117,691,294...117,887,556
Ensembl chr 4:117,743,710...117,882,464
|
|
G |
Add3 |
adducin 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ADD3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:273,854,195...273,961,982
Ensembl chr 1:273,854,248...273,961,982
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ADGRE1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865
|
|
G |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of GPR116 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:20,091,121...20,195,706
Ensembl chr 9:20,091,099...20,195,566
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADGRV1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:8,926,843...9,504,455
Ensembl chr 2:8,926,850...9,504,134
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ADH1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADH7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADHFE1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 5:9,403,194...9,429,783
Ensembl chr 5:9,403,196...9,429,859
|
|
G |
Adipor2 |
adiponectin receptor 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Adora1 |
adenosine A1 receptor |
increases response to substance |
ISO |
ADORA1 protein results in increased susceptibility to 1-Naphthylisothiocyanate |
CTD |
PMID:22956627 |
|
NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ADRA1B mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:29,392,762...29,450,644
Ensembl chr10:29,392,762...29,450,644
|
|
G |
Afm |
afamin |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AFM mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr14:19,078,678...19,132,212
Ensembl chr14:19,078,680...19,132,208
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AGL mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:219,788,234...219,843,189
Ensembl chr 2:219,788,234...219,842,986
|
|
G |
Agtpbp1 |
ATP/GTP binding protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AGTPBP1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr17:5,510,009...5,614,416
Ensembl chr17:5,511,385...5,614,435
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions decreases expression |
ISO EXP |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of AGTR1 mRNA 1-Naphthylisothiocyanate results in decreased expression of AGTR1A mRNA |
CTD |
PMID:25380136 PMID:27344345 |
|
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Agxt |
alanine--glyoxylate and serine--pyruvate aminotransferase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AGXT mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:100,281,339...100,291,292
Ensembl chr 9:100,281,339...100,291,291
|
|
G |
Ahnak |
AHNAK nucleoprotein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AHNAK mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:225,184,883...225,429,638
Ensembl chr 1:225,184,939...225,215,015
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AHR mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Aida |
axin interactor, dorsalization associated |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AIDA mRNA |
CTD |
PMID:25380136 |
|
NCBI chr13:101,698,096...101,724,928
Ensembl chr13:101,698,096...101,724,923
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AIF1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Aig1 |
androgen-induced 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AIG1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:7,816,841...8,038,805
Ensembl chr 1:7,816,838...8,038,665
|
|
G |
Ajm1 |
apical junction component 1 homolog |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AJM1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:2,799,032...2,806,686
Ensembl chr 3:2,800,650...2,803,574
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AK1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:11,652,143...11,659,135
|
|
G |
Akap11 |
A-kinase anchoring protein 11 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AKAP11 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:60,722,138...60,766,673
Ensembl chr15:60,722,160...60,766,579
|
|
G |
Akap5 |
A-kinase anchoring protein 5 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AKAP5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:99,356,509...99,361,909
Ensembl chr 6:99,356,509...99,361,909
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AKR1B1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AKR1B8 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:61,772,064...61,784,637
Ensembl chr 4:61,771,970...61,828,657
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases expression |
ISO EXP |
1-Naphthylisothiocyanate results in decreased expression of AKR1C6 mRNA 1-Naphthylisothiocyanate results in decreased expression of AKR1C1 mRNA |
CTD |
PMID:15913567 PMID:25380136 |
|
NCBI chr17:69,441,253...69,460,334
Ensembl chr17:69,441,223...69,460,321
|
|
G |
Akr1c12l1 |
aldo-keto reductase family 1, member C12-like 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AKR1C12L1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr17:69,588,119...69,599,168
Ensembl chr17:69,588,085...69,599,142
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AKR1C3 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
|
|
G |
Aktip |
AKT interacting protein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AKTIP mRNA |
CTD |
PMID:25380136 |
|
NCBI chr19:17,290,048...17,300,054
Ensembl chr19:17,290,178...17,300,050
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ALDH1A1 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression increases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ALDH1B1 mRNA 1-Naphthylisothiocyanate results in increased expression of ALDH1B1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 5:61,382,351...61,387,359
Ensembl chr 5:61,382,351...61,387,358
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
decreases expression |
EXP |
1-naphthyl isothiocyanate decreases expression of ALDH1L1 mRNA in rat liver |
RGD |
PMID:30223280 |
RGD:15045612 |
NCBI chr 4:123,516,553...123,564,067
Ensembl chr 4:123,516,788...123,557,501
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ALDH1L2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ALDOA mRNA |
CTD |
PMID:17522070 |
|
NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions increases expression increases secretion |
ISO EXP |
RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ALPL protein] 1-Naphthylisothiocyanate results in increased expression of ALPL mRNA 1-Naphthylisothiocyanate results in increased secretion of ALPL protein dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in increased secretion of ALPL protein] |
CTD |
PMID:27702592 PMID:28049044 PMID:30723492 |
|
NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AMACR mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 2:60,949,276...60,961,342
Ensembl chr 2:60,949,256...60,961,326
|
|
G |
Amdhd1 |
amidohydrolase domain containing 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AMDHD1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:34,362,635...34,406,282
Ensembl chr 7:34,361,633...34,406,318
|
|
G |
Amelx |
amelogenin, X-linked |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AMELX mRNA |
CTD |
PMID:12832660 |
|
NCBI chr X:26,439,197...26,450,495
Ensembl chr X:26,439,197...26,450,495
|
|
G |
Amigo1 |
adhesion molecule with Ig like domain 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AMIGO1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:210,977,125...210,982,582
Ensembl chr 2:210,977,938...210,982,579
|
|
G |
Ang |
angiogenin |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ANG mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:28,022,926...28,028,636
|
|
G |
Ang2 |
angiogenin, ribonuclease A family, member 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ANG2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:28,103,688...28,121,494
Ensembl chr15:28,103,703...28,104,206
|
|
G |
Angpt4 |
angiopoietin 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANGPT4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:147,421,724...147,455,670
Ensembl chr 3:147,422,095...147,455,670
|
|
G |
Angptl3 |
angiopoietin-like 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 5:117,698,590...117,706,729
Ensembl chr 5:117,698,764...117,705,808
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079
|
|
G |
Ankef1 |
ankyrin repeat and EF-hand domain containing 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANKEF1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:129,462,446...129,536,423
Ensembl chr 3:129,501,105...129,536,422
|
|
G |
Ankle1 |
ankyrin repeat and LEM domain containing 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANKLE1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:19,799,943...19,826,057
Ensembl chr16:19,800,463...19,803,796
|
|
G |
Ankrd55 |
ankyrin repeat domain 55 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ANKRD55 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:43,819,234...44,196,602
Ensembl chr 2:44,096,061...44,196,605
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANLN mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773
|
|
G |
Anlnl1 |
anillin, actin binding protein-like 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANLNL1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr17:66,542,420...66,553,118
Ensembl chr17:66,548,818...66,551,947
|
|
G |
Ano6 |
anoctamin 6 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANO6 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208
|
|
G |
Ano7 |
anoctamin 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANO7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:100,511,610...100,551,798
Ensembl chr 9:100,511,610...100,551,798
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANXA1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Anxa13 |
annexin A13 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANXA13 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:98,217,642...98,270,442
Ensembl chr 7:98,217,642...98,270,110
|
|
G |
Anxa2 |
annexin A2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANXA2 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANXA3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr14:14,371,921...14,426,503
Ensembl chr14:14,364,008...14,426,437
|
|
G |
Anxa4 |
annexin A4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANXA4 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
|
|
G |
Anxa5 |
annexin A5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ANXA5 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 2:123,162,477...123,194,730
Ensembl chr 2:123,162,461...123,193,130
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AOC1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:78,496,043...78,515,582
Ensembl chr 4:78,496,043...78,515,584
|
|
G |
Ap1s2 |
adaptor related protein complex 1 subunit sigma 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AP1S2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr X:32,329,883...32,376,301
Ensembl chr X:32,329,598...32,355,307
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of APBB1IP mRNA |
CTD |
PMID:25380136 |
|
NCBI chr17:90,098,953...90,149,192
Ensembl chr17:90,099,025...90,149,894
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of APEX1 mRNA |
CTD |
PMID:17522070 |
|
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
|
|
G |
Apmap |
adipocyte plasma membrane associated protein |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of APMAP mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:146,376,828...146,407,259
Ensembl chr 3:146,376,828...146,407,252
|
|
G |
Apoa1 |
apolipoprotein A1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of APOA1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoa4 |
apolipoprotein A4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of APOA4 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
|
|
G |
Apob |
apolipoprotein B |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOB mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997
|
|
G |
Apoc2 |
apolipoprotein C2 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOC2 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136
|
|
G |
Apoc4 |
apolipoprotein C4 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOC4 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 1:80,595,339...80,599,525
Ensembl chr 1:80,595,326...80,599,572
|
|
G |
Apof |
apolipoprotein F |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOF mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 7:2,689,501...2,690,938
Ensembl chr 7:2,689,501...2,690,936
|
|
G |
Apol9a |
apolipoprotein L 9a |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of APOL9A mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:118,927,013...118,933,778
Ensembl chr 7:118,927,008...118,933,812
|
|
G |
App |
amyloid beta precursor protein |
affects expression increases expression |
EXP |
1-Naphthylisothiocyanate affects the expression of APP mRNA 1-Naphthylisothiocyanate results in increased expression of APP mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Appl1 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of APPL1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr16:2,560,103...2,602,035
Ensembl chr16:2,563,520...2,602,103
|
|
G |
Aqp4 |
aquaporin 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AQP4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
|
|
G |
Aqp5 |
aquaporin 5 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of AQP5 mRNA |
CTD |
PMID:20551477 PMID:30723492 |
|
NCBI chr 7:141,249,044...141,252,576
Ensembl chr 7:141,249,044...141,252,578
|
|
G |
Aqp7 |
aquaporin 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AQP7 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 5:57,358,297...57,372,332
Ensembl chr 5:57,358,327...57,372,239
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
1-Naphthylisothiocyanate binds to and results in decreased activity of AR protein; 1-Naphthylisothiocyanate binds to and results in increased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Areg |
amphiregulin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AREG mRNA |
CTD |
PMID:20551477 |
|
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARHGAP11A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:105,281,827...105,298,108
Ensembl chr 3:105,281,827...105,298,108
|
|
G |
Arhgap19 |
Rho GTPase activating protein 19 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARHGAP19 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:261,015,083...261,051,515
Ensembl chr 1:261,015,123...261,051,498
|
|
G |
Arhgap9 |
Rho GTPase activating protein 9 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARHGAP9 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:70,612,650...70,620,900
Ensembl chr 7:70,612,103...70,620,890
|
|
G |
Arhgef16 |
Rho guanine nucleotide exchange factor 16 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARHGEF16 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:171,626,450...171,649,124
Ensembl chr 5:171,624,796...171,648,563
|
|
G |
Arhgef37 |
Rho guanine nucleotide exchange factor 37 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ARHGEF37 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:56,817,986...56,871,159
Ensembl chr18:56,817,988...56,870,839
|
|
G |
Arl11 |
ADP-ribosylation factor like GTPase 11 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARL11 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr15:41,639,985...41,645,685
Ensembl chr15:41,643,541...41,645,685
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARL4D mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:89,577,556...89,580,368
Ensembl chr10:89,578,212...89,580,368
|
|
G |
Arl8a |
ADP-ribosylation factor like GTPase 8A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARL8A mRNA |
CTD |
PMID:25380136 |
|
NCBI chr13:51,972,974...51,981,976
Ensembl chr13:51,972,974...51,981,976
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARPC1B mRNA |
CTD |
PMID:25380136 |
|
NCBI chr12:11,252,300...11,265,849
Ensembl chr12:11,252,296...11,265,865
|
|
G |
Arpin |
actin-related protein 2/3 complex inhibitor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARPIN mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:141,664,790...141,672,789
Ensembl chr 1:141,662,850...141,672,810
|
|
G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ARPP19 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:81,949,577...81,972,054
Ensembl chr 8:81,949,877...81,968,589
|
|
G |
Arrb2 |
arrestin, beta 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ARRB2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:8,732,907...8,745,445
Ensembl chr 2:8,732,932...8,743,069
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ASAH1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ASB2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:127,212,325...127,248,451
Ensembl chr 6:127,212,273...127,248,372
|
|
G |
Asb5 |
ankyrin repeat and SOCS box-containing 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ASB5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:39,985,233...40,050,663
Ensembl chr16:39,985,234...40,025,401
|
|
G |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ASCL1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:28,038,662...28,040,504
Ensembl chr 7:28,038,662...28,040,510
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ASF1B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:25,077,918...25,092,491
Ensembl chr19:25,077,918...25,092,491
|
|
G |
Asl |
argininosuccinate lyase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ASL mRNA |
CTD |
PMID:17522070 |
|
NCBI chr12:30,160,922...30,178,348
Ensembl chr12:30,165,694...30,178,341
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of ASNS mRNA |
CTD |
PMID:17175557 PMID:25380136 |
|
NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
|
|
G |
Aspm |
assembly factor for spindle microtubules |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ASPM mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:56,546,021...56,591,793
Ensembl chr13:56,546,021...56,591,793
|
|
G |
Aspn |
asporin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ASPN mRNA |
CTD |
PMID:25380136 |
|
NCBI chr17:14,655,958...14,681,355
Ensembl chr17:14,656,009...14,679,409
|
|
G |
Astn2 |
astrotactin 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ASTN2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:81,179,614...82,168,528
Ensembl chr 5:81,179,605...82,168,427
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ATF3 mRNA |
CTD |
PMID:20551477 PMID:25380136 |
|
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of ATF4 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ATF4 mRNA |
CTD |
PMID:20551477 PMID:27344345 |
|
NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
|
|
G |
Atg16l2 |
autophagy related 16-like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ATG16L2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:166,401,271...166,415,078
Ensembl chr 1:166,401,271...166,413,564
|
|
G |
Atp10a |
ATPase phospholipid transporting 10A (putative) |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ATP10A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:115,973,343...116,141,892
Ensembl chr 1:115,975,324...116,141,892
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ATP1A2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:90,651,682...90,676,629
Ensembl chr13:90,651,686...90,676,629
|
|
G |
Atp4a |
ATPase H+/K+ transporting subunit alpha |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ATP4A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:89,162,700...89,175,504
Ensembl chr 1:89,162,639...89,175,811
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ATP6V0D2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:33,843,591...33,892,446
Ensembl chr 5:33,843,519...33,892,462
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ATP6V1D mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 6:102,032,271...102,047,754
Ensembl chr 6:102,032,276...102,047,758
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
increases expression multiple interactions |
ISO |
1-Naphthylisothiocyanate results in increased expression of ATP8B1 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ATP8B1 mRNA] |
CTD |
PMID:19407337 PMID:28549656 |
|
NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354
|
|
G |
Atp8b2 |
ATPase phospholipid transporting 8B2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ATP8B2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:189,285,961...189,306,947
Ensembl chr 2:189,285,953...189,307,108
|
|
G |
Atrn |
attractin |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ATRN mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:123,434,409...123,567,922
Ensembl chr 3:123,434,409...123,567,918
|
|
G |
Atxn1l |
ataxin 1-like |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ATXN1L mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:41,932,356...41,939,456
|
|
G |
Atxn7l1 |
ataxin 7-like 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ATXN7L1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:52,459,930...52,680,552
Ensembl chr 6:52,459,946...52,675,574
|
|
G |
Aurkb |
aurora kinase B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AURKB mRNA; 1-Naphthylisothiocyanate results in increased expression of AURKB protein |
CTD |
PMID:23411599 PMID:30723492 |
|
NCBI chr10:55,625,860...55,632,399
Ensembl chr10:55,626,741...55,634,991
|
|
G |
Axl |
Axl receptor tyrosine kinase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of AXL mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:82,550,892...82,580,761
Ensembl chr 1:82,549,420...82,580,761
|
|
G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of B3GALNT1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:166,226,736...166,255,978
Ensembl chr 2:166,226,754...166,255,302
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of B4GALT5 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 3:164,039,731...164,055,561
Ensembl chr 3:164,039,731...164,095,878
|
|
G |
B9d1 |
B9 domain containing 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of B9D1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:47,784,294...47,794,399
Ensembl chr10:47,785,033...47,792,590 Ensembl chr10:47,785,033...47,792,590
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
increases expression multiple interactions |
ISO |
1-Naphthylisothiocyanate results in increased expression of BAAT mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of BAAT mRNA alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of BAAT mRNA] |
CTD |
PMID:25655198 PMID:27344345 |
|
NCBI chr 5:64,768,397...64,777,368
Ensembl chr 5:64,768,401...64,777,368
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BARD1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BASP1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of BAX mRNA] |
CTD |
PMID:12883083 PMID:15913567 PMID:20551477 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
affects expression |
EXP |
1-Naphthylisothiocyanate affects the expression of BBOX1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:101,425,684...101,474,848
Ensembl chr 3:101,427,055...101,474,890
|
|
G |
Bcas3 |
BCAS3, microtubule associated cell migration factor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of BCAS3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:72,756,548...73,271,851
|
|
G |
Bckdha |
branched chain keto acid dehydrogenase E1 subunit alpha |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of BCKDHA mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:82,423,291...82,452,094
Ensembl chr 1:82,423,277...82,452,281
|
|
G |
Bcl10 |
BCL10, immune signaling adaptor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BCL10 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:251,805,392...251,814,957
Ensembl chr 2:251,805,392...251,814,957
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA |
CTD |
PMID:12883083 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l11 |
BCL2 like 11 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BCL2L11 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BCL3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:80,730,758...80,745,273
Ensembl chr 1:80,730,499...80,744,831
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of BDH1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr11:72,577,547...72,619,435
Ensembl chr11:72,578,533...72,614,176
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BDKRB1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
|
|
G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BET1L mRNA |
CTD |
PMID:12832660 |
|
NCBI chr 1:213,602,836...213,606,507
Ensembl chr 1:213,602,850...213,605,643
|
|
G |
Bex3 |
brain expressed X-linked 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BEX3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr X:106,823,442...106,825,016
Ensembl chr X:106,823,491...106,825,014
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BHLHE40 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:140,703,619...140,709,319
Ensembl chr 4:140,703,619...140,709,319
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BHLHE41 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:180,230,742...180,235,138
Ensembl chr 4:180,232,382...180,234,804
|
|
G |
Bicc1 |
BicC family RNA binding protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BICC1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr20:18,780,605...18,940,429
Ensembl chr20:18,780,605...18,940,408
|
|
G |
Bicd2 |
BICD cargo adaptor 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BICD2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr17:15,673,649...15,718,035
Ensembl chr17:15,673,650...15,718,035
|
|
G |
Bicdl1 |
BICD family like cargo adaptor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BICDL1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:46,615,597...46,703,287
Ensembl chr12:46,615,649...46,703,287
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression increases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of BIRC3 mRNA 1-Naphthylisothiocyanate results in increased expression of BIRC3 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BIRC5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BLOC1S2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:263,913,901...263,920,989
Ensembl chr 1:263,913,854...263,920,962
|
|
G |
Bmf |
Bcl2 modifying factor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of BMF mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 3:110,303,515...110,324,125
Ensembl chr 3:110,306,067...110,324,084
|
|
G |
Bmp3 |
bone morphogenetic protein 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BMP3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr14:12,362,912...12,387,572
Ensembl chr14:12,359,363...12,387,102
|
|
G |
Boc |
BOC cell adhesion associated, oncogene regulated |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BOC mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:61,084,216...61,159,220
Ensembl chr11:61,083,757...61,158,838
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BOK mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:100,829,593...100,840,498
Ensembl chr 9:100,829,552...100,840,504
|
|
G |
Borcs8 |
BLOC-1 related complex subunit 8 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BORCS8 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:21,022,500...21,029,163
Ensembl chr16:21,023,996...21,029,134
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BRCA1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
|
|
G |
Btc |
betacellulin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BTC mRNA |
CTD |
PMID:30723492 |
|
NCBI chr14:18,231,854...18,270,621
Ensembl chr14:18,231,860...18,272,484
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BTG2 mRNA |
CTD |
PMID:17522070 PMID:30723492 |
|
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
|
|
G |
Btg3 |
BTG anti-proliferation factor 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BTG3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:16,873,642...16,889,100
Ensembl chr11:16,873,646...16,889,201
|
|
G |
Btla |
B and T lymphocyte associated |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of BTLA mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:60,523,692...60,547,234
Ensembl chr11:60,524,917...60,547,201
|
|
G |
Btnl2 |
butyrophilin-like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BTNL2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr20:4,140,184...4,156,365
Ensembl chr20:4,141,878...4,154,978
|
|
G |
Btnl7 |
butyrophilin-like 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BTNL7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr20:2,757,008...2,769,215
Ensembl chr20:2,757,004...2,768,426
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BUB1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:120,373,604...120,404,910
Ensembl chr 3:120,373,604...120,404,910
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of BUB1B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458
|
|
G |
C1qa |
complement C1q A chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of C1QA mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 5:155,261,254...155,264,101
Ensembl chr 5:155,261,250...155,264,143
|
|
G |
C1qb |
complement C1q B chain |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of C1QB mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C1QB mRNA |
CTD |
PMID:25380136 PMID:27344345 |
|
NCBI chr 5:155,246,444...155,251,995
Ensembl chr 5:155,246,447...155,252,003
|
|
G |
C1qc |
complement C1q C chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of C1QC mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 5:155,255,013...155,258,631
Ensembl chr 5:155,255,005...155,258,392
|
|
G |
C3 |
complement C3 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C3 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of C4BPA mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:47,342,090...47,377,580
Ensembl chr13:47,342,079...47,377,703
|
|
G |
C4bpb |
complement component 4 binding protein, beta |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C4BPB mRNA |
CTD |
PMID:27344345 |
|
NCBI chr13:47,387,173...47,398,115
Ensembl chr13:47,387,173...47,397,890
|
|
G |
C5 |
complement C5 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C5 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 3:14,049,993...14,113,931 NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
|
|
G |
C5ar1 |
complement C5a receptor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of C5AR1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:78,186,777...78,195,132
Ensembl chr 1:78,186,776...78,195,328
|
|
G |
C7 |
complement C7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of C7 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:54,707,621...54,781,624
Ensembl chr 2:54,709,138...54,777,729
|
|
G |
C8g |
complement C8 gamma chain |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of C8G mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:2,724,616...2,727,616
Ensembl chr 3:2,724,616...2,727,616
|
|
G |
C9 |
complement C9 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C9 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 2:55,775,562...55,823,807
Ensembl chr 2:55,775,274...55,823,826
|
|
G |
Ca3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CAR3 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Ca5a |
carbonic anhydrase 5A |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CAR5A mRNA |
CTD |
PMID:25380136 |
|
NCBI chr19:54,731,829...54,761,697
Ensembl chr19:54,731,859...54,761,670
|
|
G |
Cabp2 |
calcium binding protein 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CABP2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:219,329,186...219,335,046
Ensembl chr 1:219,329,574...219,335,043
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CACNA1D mRNA |
CTD |
PMID:12832660 |
|
NCBI chr16:6,110,294...6,405,022
Ensembl chr16:6,112,150...6,405,117
|
|
G |
Cacna2d3 |
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CACNA2D3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:4,871,348...5,795,825
Ensembl chr16:4,871,650...5,795,825
|
|
G |
Cacna2d4 |
calcium voltage-gated channel auxiliary subunit alpha2delta 4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CACNA2D4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:151,298,548...151,409,263
Ensembl chr 4:151,298,548...151,409,263
|
|
G |
Calcb |
calcitonin-related polypeptide, beta |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CALCB mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:184,271,116...184,276,480
Ensembl chr 1:184,271,590...184,276,475
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CALM1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:124,217,241...124,225,292
Ensembl chr 6:124,217,241...124,225,292
|
|
G |
Calu |
calumenin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CALU mRNA |
CTD |
PMID:17522070 |
|
NCBI chr 4:56,625,611...56,653,112
Ensembl chr 4:56,625,561...56,653,111
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CAMK2D mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:230,900,907...231,132,207
Ensembl chr 2:230,901,126...231,132,039
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CAMK2N1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:156,876,706...156,878,486
Ensembl chr 5:156,876,706...156,878,486
|
|
G |
Camkmt |
calmodulin-lysine N-methyltransferase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CAMKMT mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:8,346,645...8,729,773
Ensembl chr 6:8,669,722...8,729,771
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CAPG mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
|
|
G |
Capn13 |
calpain 13 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CAPN13 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:24,579,590...24,676,536
Ensembl chr 6:24,579,622...24,676,524
|
|
G |
Capn9 |
calpain 9 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CAPN9 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:57,341,938...57,378,901
Ensembl chr19:57,341,938...57,378,901
|
|
G |
Casp1 |
caspase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CASP1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
|
|
G |
Casp12 |
caspase 12 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CASP12 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
EXP |
1-Naphthylisothiocyanate results in increased cleavage of CASP3 protein |
CTD |
PMID:26011634 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp4 |
caspase 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CASP4 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:2,616,391...2,651,682
Ensembl chr 8:2,635,851...2,651,652
|
|
G |
Casp7 |
caspase 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CASP7 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Cat |
catalase |
decreases expression multiple interactions |
ISO EXP |
1-Naphthylisothiocyanate results in decreased expression of CAT mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CAT mRNA |
CTD |
PMID:15913567 PMID:17522070 PMID:27344345 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cavin2 |
caveolae associated protein 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CAVIN2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:55,244,136...55,256,153
Ensembl chr 9:55,243,255...55,256,340
|
|
G |
Cblc |
Cbl proto-oncogene C |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CBLC mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:80,699,321...80,716,146
Ensembl chr 1:80,699,323...80,716,146
|
|
G |
Cbln3 |
cerebellin 3 precursor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CBLN3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:34,548,102...34,550,938
Ensembl chr15:34,548,295...34,550,860
|
|
G |
Cbx7 |
chromobox 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CBX7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
|
|
G |
Ccdc126 |
coiled-coil domain containing 126 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CCDC126 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 4:78,982,022...79,003,052
Ensembl chr 4:78,981,987...79,003,053
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCDC180 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:61,467,799...61,542,675
Ensembl chr 5:61,474,000...61,542,653
|
|
G |
Ccdc34 |
coiled-coil domain containing 34 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCDC34 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:101,156,212...101,191,363
Ensembl chr 3:101,156,212...101,191,363
|
|
G |
Ccdc68 |
coiled-coil domain containing 68 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCDC68 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:68,408,812...68,472,323
Ensembl chr18:68,408,890...68,472,320
|
|
G |
Ccdc92 |
coiled-coil domain containing 92 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCDC92 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:37,210,735...37,237,848
Ensembl chr12:37,211,316...37,237,848
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCL11 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO EXP |
[FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CCL2 mRNA; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA] 1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA; 1-Naphthylisothiocyanate results in increased expression of CCL2 protein |
CTD |
PMID:21037076 PMID:21356363 PMID:22094456 PMID:25051504 PMID:26921287 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCL20 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CCL24 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:24,131,529...24,152,626
Ensembl chr12:24,148,567...24,152,625
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression multiple interactions |
ISO |
1-Naphthylisothiocyanate results in increased expression of CCL3 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCL3 mRNA] |
CTD |
PMID:15913567 PMID:26921287 |
|
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
1-Naphthylisothiocyanate results in increased expression of CCL4 mRNA |
CTD |
PMID:26921287 |
|
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
affects expression decreases expression increases expression |
EXP |
1-Naphthylisothiocyanate affects the expression of CCL5 protein 1-Naphthylisothiocyanate results in decreased expression of CCL5 mRNA 1-Naphthylisothiocyanate results in increased expression of CCL5 mRNA |
CTD |
PMID:25051504 PMID:25380136 PMID:30723492 |
|
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCN1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCN2 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCN3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:94,375,134...94,382,154
Ensembl chr 7:94,375,020...94,383,024
|
|
G |
Ccn4 |
cellular communication network factor 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCN4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:107,695,227...107,723,759
Ensembl chr 7:107,695,215...107,723,772
|
|
G |
Ccn5 |
cellular communication network factor 5 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CCN5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:160,207,969...160,219,316
Ensembl chr 3:160,207,913...160,219,331
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCNA2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression multiple interactions |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CCNB1 protein obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein]]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein] |
CTD |
PMID:29660435 PMID:30723492 |
|
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression increases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CCNB2 mRNA 1-Naphthylisothiocyanate results in increased expression of CCNB2 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 8:76,847,972...76,861,165
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CCND1 protein O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein]]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein] |
CTD |
PMID:15913567 PMID:29660435 PMID:30723492 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccne1 |
cyclin E1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCNE1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CCNG1 mRNA |
CTD |
PMID:17522070 PMID:18289764 PMID:25380136 |
|
NCBI chr10:25,903,925...25,910,298
Ensembl chr10:25,903,911...25,910,325
|
|
G |
Ccnj |
cyclin J |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CCNJ mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:259,926,537...259,944,275
Ensembl chr 1:260,093,641...260,111,254 Ensembl chr 1:260,093,641...260,111,254
|
|
G |
Cd163 |
CD163 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD163 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:156,752,063...156,785,467
Ensembl chr 4:156,752,082...156,785,467
|
|
G |
Cd19 |
CD19 molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD19 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:197,815,422...197,822,123
Ensembl chr 1:197,815,413...197,821,936
|
|
G |
Cd207 |
CD207 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD207 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:115,333,124...115,355,034
Ensembl chr 4:115,348,491...115,354,795
|
|
G |
Cd226 |
CD226 molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD226 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:86,299,392...86,394,772
Ensembl chr18:86,299,463...86,394,765
|
|
G |
Cd24 |
CD24 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD24 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr20:48,335,540...48,340,847
Ensembl chr20:48,335,540...48,340,846
|
|
G |
Cd247 |
Cd247 molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD247 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:83,996,045...84,071,408
Ensembl chr13:83,996,080...84,071,400
|
|
G |
Cd274 |
CD274 molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD274 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:247,519,890...247,539,659
Ensembl chr 1:247,519,939...247,537,943
|
|
G |
Cd276 |
Cd276 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD276 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 8:63,312,060...63,350,411
Ensembl chr 8:63,318,019...63,350,269
|
|
G |
Cd300e |
Cd300e molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD300E mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:103,599,372...103,619,070
Ensembl chr10:103,599,103...103,619,083
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD36 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd38 |
CD38 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD38 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr14:71,714,768...71,754,990
Ensembl chr14:71,715,269...71,754,672
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD44 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd48 |
Cd48 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD48 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr13:90,116,601...90,140,371
Ensembl chr13:90,116,843...90,140,371
|
|
G |
Cd53 |
Cd53 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD53 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:209,489,279...209,537,098
Ensembl chr 2:209,489,279...209,537,087
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CD55 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
|
|
G |
Cd5l |
Cd5 molecule-like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD5L mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:186,685,104...186,696,117
Ensembl chr 2:186,685,104...186,696,117
|
|
G |
Cd63 |
Cd63 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD63 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
|
|
G |
Cd68 |
Cd68 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD68 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
|
|
G |
Cd7 |
Cd7 molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD7 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:110,229,931...110,232,812
Ensembl chr10:110,229,922...110,232,843
|
|
G |
Cd72 |
Cd72 molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD72 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:58,943,021...58,950,373
Ensembl chr 5:58,943,027...58,950,373
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD74 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849
|
|
G |
Cd79b |
CD79b molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD79B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:94,497,445...94,500,591
Ensembl chr10:94,497,448...94,500,591
|
|
G |
Cd83 |
CD83 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD83 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr17:24,416,651...24,435,790
Ensembl chr17:24,416,651...24,435,790
|
|
G |
Cd8a |
CD8a molecule |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CD8A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:99,217,640...99,243,352
Ensembl chr 4:99,239,115...99,243,351
|
|
G |
Cd9 |
CD9 molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CD9 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
|
|
G |
Cdc20 |
cell division cycle 20 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDC20 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:137,260,728...137,264,931
Ensembl chr 5:137,260,739...137,265,015
|
|
G |
Cdc25c |
cell division cycle 25C |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDC25C mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:27,528,768...27,550,316
Ensembl chr18:27,528,354...27,550,224
|
|
G |
Cdc42ep5 |
CDC42 effector protein 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDC42EP5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:73,717,207...73,719,600
Ensembl chr 1:73,719,005...73,719,529
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:196,402,837...196,410,664
Ensembl chr 2:196,402,837...196,410,659
|
|
G |
Cdc45 |
cell division cycle 45 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDC45 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453
|
|
G |
Cdc7 |
cell division cycle 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDC7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr14:3,826,658...3,846,891
Ensembl chr14:3,826,659...3,846,891
|
|
G |
Cdca2 |
cell division cycle associated 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDCA2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:44,365,396...44,411,601
Ensembl chr15:44,365,405...44,411,004
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDCA3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:157,347,876...157,351,889
Ensembl chr 4:157,348,020...157,351,604
|
|
G |
Cdca8 |
cell division cycle associated 8 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDCA8 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:142,911,310...142,933,536
Ensembl chr 5:142,911,305...142,933,526
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDH3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:38,668,957...38,719,801
Ensembl chr19:38,669,230...38,719,677
|
|
G |
Cdhr5 |
cadherin-related family member 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDHR5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:214,255,118...214,263,848
Ensembl chr 1:214,255,110...214,263,581
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDK1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CDK10 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:56,024,903...56,032,610
Ensembl chr19:56,024,903...56,032,605
|
|
G |
Cdkl2 |
cyclin dependent kinase like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDKL2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr14:17,530,170...17,565,950
Ensembl chr14:17,531,398...17,565,950
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDKN1A mRNA; 1-Naphthylisothiocyanate results in increased expression of CDKN1A protein |
CTD |
PMID:20551477 PMID:23411599 PMID:25380136 PMID:26011634 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CDKN1B mRNA |
CTD |
PMID:20551477 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDKN2AIPNL mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:37,422,647...37,432,082
Ensembl chr10:37,422,647...37,432,081
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDKN2B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
decreases expression increases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CDKN3 mRNA 1-Naphthylisothiocyanate results in increased expression of CDKN3 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CDT1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:55,381,565...55,386,511
Ensembl chr19:55,381,565...55,386,511
|
|
G |
Ceacam4 |
CEA cell adhesion molecule 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CEACAM4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:81,643,809...81,650,085
Ensembl chr 1:81,643,816...81,650,094
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CEBPB mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CEBPD mRNA |
CTD |
PMID:25380136 |
|
NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
|
|
G |
Celf5 |
CUGBP, Elav-like family member 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CELF5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:11,095,449...11,119,941
Ensembl chr 7:11,095,468...11,119,941
|
|
G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CELSR1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:126,774,010...126,914,085
Ensembl chr 7:126,775,516...126,913,585
|
|
G |
Cemip |
cell migration inducing hyaluronidase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CEMIP mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:146,069,774...146,226,320
Ensembl chr 1:146,069,771...146,226,462
|
|
G |
Cemip2 |
cell migration inducing hyaluronidase 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CEMIP2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:239,397,322...239,474,931
Ensembl chr 1:239,398,043...239,474,931
|
|
G |
Cenpa |
centromere protein A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPA mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:27,072,259...27,080,863
Ensembl chr 6:27,072,166...27,080,856
|
|
G |
Cenpe |
centromere protein E |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPE mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:240,395,974...240,454,785
Ensembl chr 2:240,396,152...240,454,747
|
|
G |
Cenpf |
centromere protein F |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPF mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:108,132,499...108,178,609
Ensembl chr13:108,132,499...108,178,609
|
|
G |
Cenph |
centromere protein H |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPH mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:30,766,637...30,780,123
Ensembl chr 2:30,766,590...30,780,121
|
|
G |
Cenpi |
centromere protein I |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPI mRNA |
CTD |
PMID:30723492 |
|
NCBI chr X:105,147,045...105,198,798
Ensembl chr X:105,147,153...105,198,797
|
|
G |
Cenpq |
centromere protein Q |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPQ mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:23,352,271...23,368,774
|
|
G |
Cenpt |
centromere protein T |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPT mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:37,813,284...37,819,782
Ensembl chr19:37,812,751...37,819,789
|
|
G |
Cenpu |
centromere protein U |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPU mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:48,898,032...48,921,248
Ensembl chr16:48,897,982...48,921,242
|
|
G |
Cenpw |
centromere protein W |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CENPW mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:29,915,443...29,920,598
Ensembl chr 1:29,915,443...29,920,598
|
|
G |
Cep128 |
centrosomal protein 128 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CEP128 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:114,759,474...115,158,004
Ensembl chr 6:114,759,474...115,157,854
|
|
G |
Cep55 |
centrosomal protein 55 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CEP55 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:256,745,251...256,760,794
Ensembl chr 1:256,745,288...256,760,796
|
|
G |
Cers3 |
ceramide synthase 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CERS3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:127,706,618...127,781,041
Ensembl chr 1:127,648,234...127,781,017
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CES1D mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
|
|
G |
Ces2h |
carboxylesterase 2H |
multiple interactions increases expression |
ISO EXP |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CES2 mRNA 1-Naphthylisothiocyanate results in increased expression of CES2 mRNA |
CTD |
PMID:27344345 PMID:30723492 |
|
NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CFAP20 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:10,024,938...10,038,838
Ensembl chr19:10,024,947...10,038,784
|
|
G |
Cfap91 |
cilia and flagella associated protein 91 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CFAP91 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:64,975,499...65,019,169
Ensembl chr11:64,975,594...65,018,108
|
|
G |
Cfd |
complement factor D |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CFD mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:12,634,216...12,635,939
Ensembl chr 7:12,634,216...12,635,943
|
|
G |
Cfh |
complement factor H |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CFH mRNA |
CTD |
PMID:27344345 |
|
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Cfp |
complement factor properdin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CFP mRNA |
CTD |
PMID:25380136 |
|
NCBI chr X:1,311,121...1,316,683
Ensembl chr X:1,311,121...1,316,682
|
|
G |
Cgas |
cyclic GMP-AMP synthase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CGAS mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:85,789,515...85,804,008
Ensembl chr 8:85,789,763...85,803,433
|
|
G |
Cggbp1 |
CGG triplet repeat binding protein 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CGGBP1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:1,896,166...1,915,603
Ensembl chr11:1,896,209...1,915,587
|
|
G |
Chaf1a |
chromatin assembly factor 1 subunit A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CHAF1A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:11,000,869...11,027,631
Ensembl chr 9:11,001,129...11,027,506
|
|
G |
Chaf1b |
chromatin assembly factor 1 subunit B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CHAF1B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:34,101,248...34,121,371
Ensembl chr11:34,101,197...34,121,378
|
|
G |
Chka |
choline kinase alpha |
increases expression decreases expression |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of CHKA mRNA 1-Naphthylisothiocyanate results in decreased expression of CHKA mRNA |
CTD |
PMID:27853831 PMID:30723492 |
|
NCBI chr 1:219,076,618...219,126,221
Ensembl chr 1:219,077,771...219,126,220
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CHPT1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:29,019,518...29,070,928
Ensembl chr 7:29,043,916...29,070,928
|
|
G |
Chrd |
chordin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CHRD mRNA |
CTD |
PMID:12832660 |
|
NCBI chr11:83,858,503...83,867,543
Ensembl chr11:83,858,503...83,867,203
|
|
G |
Chrdl2 |
chordin-like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CHRDL2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:165,008,997...165,036,431
Ensembl chr 1:165,008,912...165,036,435
|
|
G |
Chrna2 |
cholinergic receptor nicotinic alpha 2 subunit |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CHRNA2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:42,808,897...42,825,179
Ensembl chr15:42,808,897...42,825,179
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CHRNA5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:59,561,817...59,590,172
Ensembl chr 8:59,561,721...59,590,172
|
|
G |
Chrne |
cholinergic receptor nicotinic epsilon subunit |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CHRNE mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:57,238,960...57,246,750
Ensembl chr10:57,238,946...57,243,435
|
|
G |
Chst4 |
carbohydrate sulfotransferase 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CHST4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:41,630,060...41,642,373
Ensembl chr19:41,631,715...41,640,367
|
|
G |
Chsy1 |
chondroitin sulfate synthase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CHSY1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:127,010,587...127,071,570
Ensembl chr 1:127,010,588...127,071,570
|
|
G |
Chtf18 |
chromosome transmission fidelity factor 18 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CHTF18 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:15,090,762...15,098,825
Ensembl chr10:15,090,316...15,098,791
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CIDEA mRNA |
CTD |
PMID:25380136 |
|
NCBI chr18:63,082,861...63,108,450
Ensembl chr18:63,098,144...63,108,051
|
|
G |
Cip2a |
cellular inhibitor of PP2A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CIP2A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:54,373,794...54,404,704
Ensembl chr11:54,377,374...54,404,612
|
|
G |
Cirbp |
cold inducible RNA binding protein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CIRBP mRNA |
CTD |
PMID:12832660 |
|
NCBI chr 7:12,400,066...12,405,054
Ensembl chr 7:12,401,207...12,405,022
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CITED4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:139,597,731...139,598,622
Ensembl chr 5:139,597,731...139,598,622
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CKAP2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:74,752,655...74,779,184
Ensembl chr16:74,752,655...74,779,184
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CKAP2L mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:121,796,221...121,822,352
Ensembl chr 3:121,796,238...121,822,436
|
|
G |
Ckap4 |
cytoskeleton-associated protein 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CKAP4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:24,935,243...24,947,595
Ensembl chr 7:24,939,498...24,947,595
|
|
G |
Clca4l |
chloride channel calcium activated 4-like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLCA4L mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:250,785,534...250,805,445
Ensembl chr 2:250,785,534...250,805,445
|
|
G |
Clcn6 |
chloride voltage-gated channel 6 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLCN6 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:164,811,815...164,844,554
Ensembl chr 5:164,811,816...164,844,586
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CLDN1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416
|
|
G |
Cldn23 |
claudin 23 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLDN23 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:59,988,603...59,990,327
Ensembl chr16:59,988,603...59,990,326
|
|
G |
Cldn4 |
claudin 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLDN4 mRNA |
CTD |
PMID:20551477 PMID:30723492 |
|
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
|
|
G |
Cldn6 |
claudin 6 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLDN6 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:12,999,256...13,002,860
Ensembl chr10:13,000,090...13,002,862
|
|
G |
Cldn7 |
claudin 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLDN7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:56,576,326...56,578,632
Ensembl chr10:56,576,428...56,578,626
|
|
G |
Cldn9 |
claudin 9 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLDN9 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:13,003,010...13,004,441
Ensembl chr10:13,003,011...13,004,441
|
|
G |
Clec4a3 |
C-type lectin domain family 4, member A3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLEC4A mRNA; 1-Naphthylisothiocyanate results in increased expression of CLEC4A1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:155,913,366...155,923,079
Ensembl chr 4:155,913,366...155,923,079
|
|
G |
Clec5a |
C-type lectin domain containing 5A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLEC5A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:68,810,330...68,819,921
Ensembl chr 4:68,808,359...68,819,928
|
|
G |
Clic1 |
chloride intracellular channel 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLIC1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr20:5,040,314...5,049,166
Ensembl chr20:5,040,337...5,049,166
|
|
G |
Clp1 |
cleavage factor polyribonucleotide kinase subunit 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CLP1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:72,125,269...72,137,122
Ensembl chr 3:72,125,273...72,128,973
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CLPX mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:70,789,137...70,843,133
Ensembl chr 8:70,789,256...70,843,123
|
|
G |
Clspn |
claspin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLSPN mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:144,577,670...144,617,507
Ensembl chr 5:144,581,427...144,616,335
|
|
G |
Clstn3 |
calsyntenin 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CLSTN3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:157,044,736...157,078,013
Ensembl chr 4:157,043,925...157,078,130
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLTRN mRNA |
CTD |
PMID:30723492 |
|
NCBI chr X:32,118,082...32,153,687
Ensembl chr X:32,118,054...32,153,794
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CLU mRNA |
CTD |
PMID:17522070 PMID:18289764 PMID:30723492 |
|
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CMTM3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr19:830,874...838,528
Ensembl chr19:830,877...838,099
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CNDP1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr18:81,466,717...81,512,841
Ensembl chr18:81,466,716...81,499,051
|
|
G |
Cngb1 |
cyclic nucleotide gated channel subunit beta 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CNGB1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:10,142,440...10,206,618
Ensembl chr19:10,142,496...10,206,681
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CNP mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr10:88,490,798...88,497,357
Ensembl chr10:88,490,798...88,497,356
|
|
G |
Cntfr |
ciliary neurotrophic factor receptor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CNTFR mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:58,041,114...58,078,687
Ensembl chr 5:58,041,146...58,078,545
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL11A1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:216,863,423...217,056,523
Ensembl chr 2:216,863,428...217,056,523
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL12A1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 8:87,042,820...87,150,701
Ensembl chr 8:87,040,799...87,158,368
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of COL18A1 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; Tranexamic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA] 1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA; 1-Naphthylisothiocyanate results in increased expression of COL1A1 protein |
CTD |
PMID:21037076 PMID:22094456 PMID:24633426 PMID:25380136 PMID:26921287 PMID:28049044 PMID:30723492 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL1A2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of COL3A1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of COL3A1 mRNA |
CTD |
PMID:25380136 PMID:27344345 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of COL4A1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of COL4A1 mRNA |
CTD |
PMID:25380136 PMID:27344345 |
|
NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL4A2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr16:83,386,388...83,522,169
Ensembl chr16:83,387,364...83,438,561
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of COL4A3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:88,357,528...88,484,735
Ensembl chr 9:88,357,556...88,485,830
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL5A1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL5A2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 9:52,091,088...52,238,735
Ensembl chr 9:52,092,511...52,238,564
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL6A1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr20:12,657,913...12,676,370
Ensembl chr20:12,658,065...12,675,561
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL6A2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COL6A3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:97,926,784...98,004,643
Ensembl chr 9:97,926,787...98,004,546
|
|
G |
Colec12 |
collectin sub-family member 12 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COLEC12 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr18:867,048...1,054,047
Ensembl chr18:867,048...1,052,606
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of COLQ mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:7,626,380...7,681,621
Ensembl chr16:7,627,603...7,681,576
|
|
G |
Comp |
cartilage oligomeric matrix protein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COMP mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:20,798,437...20,807,070
Ensembl chr16:20,798,437...20,807,070
|
|
G |
Coq10a |
coenzyme Q10A |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of COQ10A mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 7:2,780,930...2,788,189
Ensembl chr 7:2,780,930...2,786,949
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of COTL1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr19:52,465,074...52,499,433
Ensembl chr19:52,465,087...52,499,433
|
|
G |
Cp |
ceruloplasmin |
increases expression |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of CP mRNA |
CTD |
PMID:15913567 PMID:18289764 |
|
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CPQ mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:71,709,174...72,167,413
Ensembl chr 7:71,709,157...72,167,417
|
|
G |
Cpvl |
carboxypeptidase, vitellogenic-like |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CPVL mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:84,026,851...84,137,172
Ensembl chr 4:84,025,926...84,131,030
|
|
G |
Cpxm2 |
carboxypeptidase X (M14 family), member 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CPXM2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:204,048,785...204,161,090
Ensembl chr 1:204,048,785...204,087,001
|
|
G |
Cracr2a |
calcium release activated channel regulator 2A |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CRACR2A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:160,143,160...160,238,744
Ensembl chr 4:160,168,297...160,194,038
|
|
G |
Creb5 |
cAMP responsive element binding protein 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CREB5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:83,390,782...83,840,356
Ensembl chr 4:83,391,283...83,836,351
|
|
G |
Crebzf |
CREB/ATF bZIP transcription factor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CREBZF mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:156,290,215...156,296,891
Ensembl chr 1:156,294,519...156,296,161
|
|
G |
Crip1 |
cysteine rich protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CRIP mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 6:137,959,171...137,967,042
Ensembl chr 6:137,959,171...137,967,042
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CRLF1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:20,675,042...20,686,365
Ensembl chr16:20,675,042...20,686,317
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CROT mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 4:22,079,837...22,116,265
Ensembl chr 4:22,081,604...22,116,265
|
|
G |
Crtap |
cartilage associated protein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CRTAP mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:122,382,613...122,402,209
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CRYAB mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:55,178,543...55,182,546
Ensembl chr 8:55,178,289...55,182,545
|
|
G |
Crym |
crystallin, mu |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CRYM mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:189,944,895...189,960,069
Ensembl chr 1:189,944,895...189,960,073
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CSF1R mRNA |
CTD |
PMID:25380136 |
|
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Cthrc1 |
collagen triple helix repeat containing 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CTHRC1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:77,966,722...77,977,004
Ensembl chr 7:77,966,722...77,977,004
|
|
G |
Ctnna3 |
catenin alpha 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CTNNA3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr20:25,063,124...26,640,428
Ensembl chr20:26,516,836...26,589,209
|
|
G |
Ctse |
cathepsin E |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CTSE mRNA |
CTD |
PMID:25380136 |
|
NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490
|
|
G |
Ctsl |
cathepsin L |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CTSL mRNA |
CTD |
PMID:17522070 |
|
NCBI chr17:1,873,105...1,879,266
Ensembl chr17:1,872,848...1,879,279
|
|
G |
Ctss |
cathepsin S |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CTSS mRNA |
CTD |
PMID:18289764 PMID:25380136 |
|
NCBI chr 2:197,655,780...197,679,768
Ensembl chr 2:197,655,786...197,679,458
|
|
G |
Ctsz |
cathepsin Z |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CTSZ mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:172,527,107...172,537,877
Ensembl chr 3:172,527,107...172,537,877
|
|
G |
Cttnbp2nl |
CTTNBP2 N-terminal like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CTTNBP2NL mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:207,495,056...207,541,808
Ensembl chr 2:207,495,055...207,541,645
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CXADR mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr11:16,826,269...16,873,564
Ensembl chr11:16,826,399...16,873,562
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions increases expression |
EXP |
Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA] |
CTD |
PMID:18364083 PMID:18590720 PMID:25380136 PMID:30723492 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
affects expression multiple interactions increases expression |
EXP ISO |
1-Naphthylisothiocyanate affects the expression of CXCL10 protein [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CXCL10 mRNA 1-Naphthylisothiocyanate results in increased expression of CXCL10 mRNA |
CTD |
PMID:25051504 PMID:25380136 PMID:27344345 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
affects expression decreases expression |
EXP |
1-Naphthylisothiocyanate affects the expression of CXCL12 mRNA 1-Naphthylisothiocyanate results in decreased expression of CXCL12 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CXCL13 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207
|
|
G |
Cxcl16 |
C-X-C motif chemokine ligand 16 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CXCL16 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr10:57,060,005...57,064,600
Ensembl chr10:57,060,007...57,064,600
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases expression |
EXP ISO |
Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA] [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL2 mRNA; [Progesterone co-treated with 1-Naphthylisothiocyanate] results in increased expression of CXCL2 mRNA; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]] 1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA; 1-Naphthylisothiocyanate results in increased expression of CXCL2 protein |
CTD |
PMID:15130876 PMID:18364083 PMID:18590720 PMID:20594950 PMID:21070799 PMID:21356363 PMID:22094456 PMID:22157104 PMID:25051504 PMID:27853831 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions increases expression |
ISO EXP |
[FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL1 mRNA; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]]; Progesterone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA] 1-Naphthylisothiocyanate results in increased expression of CXCL3 mRNA 1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CXCL1 protein |
CTD |
PMID:21070799 PMID:21356363 PMID:22094456 PMID:22157104 PMID:27853831 PMID:30723492 |
|
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
|
|
G |
Cxxc4 |
CXXC finger protein 4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CXXC4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:239,414,882...239,439,640
Ensembl chr 2:239,415,046...239,439,568
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:17522070 |
|
NCBI chr 7:124,024,003...124,041,564
Ensembl chr 7:124,023,995...124,041,594
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYBA mRNA |
CTD |
PMID:25380136 |
|
NCBI chr19:55,249,634...55,257,824
Ensembl chr19:55,249,616...55,257,876
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYBB mRNA |
CTD |
PMID:25380136 |
|
NCBI chr X:14,578,330...14,610,049
Ensembl chr X:14,578,264...14,612,547
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP1A1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP1A1 protein |
CTD |
PMID:12832660 PMID:15598703 PMID:20551477 PMID:30723492 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression decreases expression |
EXP ISO |
[1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] results in decreased expression of CYP1A2 protein [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA 1-Naphthylisothiocyanate results in increased expression of CYP1A2 mRNA 1-Naphthylisothiocyanate results in decreased expression of CYP1A2 protein |
CTD |
PMID:15598703 PMID:20551477 PMID:27344345 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP1B1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP26A1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
EXP ISO |
1-Naphthylisothiocyanate results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:24120425 PMID:25655198 PMID:30517764 |
|
NCBI chr 9:81,968,285...81,998,213
Ensembl chr 9:81,968,332...81,998,169
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP2A1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:83,711,223...83,725,222
Ensembl chr 1:83,653,234...83,766,484
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
increases expression decreases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP2A2 mRNA 1-Naphthylisothiocyanate results in decreased expression of CYP2A2 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 1:83,744,229...83,766,490
Ensembl chr 1:83,653,234...83,766,484
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression multiple interactions |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP2B1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein] |
CTD |
PMID:30723492 PMID:32198087 |
|
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP2B2 mRNA |
CTD |
PMID:26365562 PMID:30723492 |
|
NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP2B6 mRNA |
CTD |
PMID:20551477 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in decreased expression of CYP2C11 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP2C9 mRNA |
CTD |
PMID:25380136 PMID:27344345 PMID:30723492 |
|
NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
|
|
G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP2C12 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:258,709,726...258,766,873
Ensembl chr 1:258,709,721...258,766,881
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP2C13 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:258,796,624...258,877,023
Ensembl chr 1:258,796,622...258,877,045
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP2C22 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:259,257,658...259,297,270
Ensembl chr 1:259,257,657...259,287,684
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP2C24 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176
|
|
G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP2D3 mRNA |
CTD |
PMID:17522070 |
|
NCBI chr 7:123,634,400...123,638,757
Ensembl chr 7:123,625,590...123,638,765
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP2D4 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:15913567 PMID:30723492 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
decreases expression |
ISO |
1-Naphthylisothiocyanate results in decreased expression of CYP2F2 mRNA |
CTD |
PMID:15913567 |
|
NCBI chr 1:83,933,974...83,947,804
Ensembl chr 1:83,933,942...83,947,821
|
|
G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP2J3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:115,196,982...115,222,084
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP2T1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:83,965,370...83,969,466
Ensembl chr 1:83,965,608...83,969,559
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP3A18 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:10,636,294...10,684,273
Ensembl chr12:10,636,275...10,684,278
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP3A2 mRNA |
CTD |
PMID:26365562 PMID:30723492 |
|
NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:12883083 |
|
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP3A4 protein 1-Naphthylisothiocyanate results in increased expression of CYP3A11 mRNA ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 protein] |
CTD |
PMID:25655198 PMID:32198087 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP3A9 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:134,492,734...134,507,158
Ensembl chr 5:134,492,756...134,507,154
|
|
G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP4A2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:134,196,910...134,207,888
Ensembl chr 5:134,196,912...134,207,863
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP4A3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:134,468,666...134,484,851
Ensembl chr 5:134,469,270...134,484,839
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP4B1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:134,508,728...134,526,103
Ensembl chr 5:134,508,730...134,526,089
|
|
G |
Cyp4f39 |
cytochrome P450, family 4, subfamily f, polypeptide 39 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP4F39 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:14,435,024...14,514,960
Ensembl chr 7:14,441,476...14,515,212
|
|
G |
Cyp4v3 |
cytochrome P450, family 4, subfamily v, polypeptide 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP4V3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:50,111,803...50,136,741
Ensembl chr16:50,111,306...50,136,727
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYP51 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression multiple interactions increases expression |
ISO EXP |
1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein 1-naphthyl isothiocyanate decreases expression of Cyp7a1 protein in rat liver resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] 1-Naphthylisothiocyanate results in increased expression of CYP7A1 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP7A1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP7A1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP7A1 protein; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein]; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] |
CTD |
PMID:14623915 PMID:20551477 PMID:24120425 PMID:25418378 PMID:25655198 PMID:26365562 PMID:27853831 PMID:28549656 PMID:29660435 PMID:29968724 PMID:30352267 PMID:30517764 PMID:30723492 PMID:32579994, PMID:29655695 |
RGD:15090803 |
NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
decreases expression multiple interactions |
ISO |
1-Naphthylisothiocyanate results in decreased expression of CYP7B1 mRNA [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP7B1 mRNA |
CTD |
PMID:28549656 PMID:29968724 PMID:30517764 |
|
NCBI chr 2:102,701,903...102,871,257
Ensembl chr 2:102,701,903...102,871,257
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP8B1 mRNA 1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP8B1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP8B1 protein; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA] |
CTD |
PMID:14623915 PMID:24120425 PMID:25655198 PMID:27344345 PMID:29660435 PMID:29968724 PMID:30352267 PMID:30517764 PMID:30723492 PMID:32579994 |
|
NCBI chr 8:130,548,418...130,550,388
Ensembl chr 8:130,548,418...130,550,388
|
|
G |
Cyrib |
CYFIP related Rac1 interactor B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYRIB mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:104,514,566...104,641,875
Ensembl chr 7:104,516,391...104,556,419
|
|
G |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of CYSTM1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr18:29,165,206...29,233,351
Ensembl chr18:29,191,731...29,232,978
|
|
G |
Cytl1 |
cytokine like 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of CYTL1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr14:77,805,137...77,810,147
Ensembl chr14:77,805,130...77,810,147
|
|
G |
Dab1 |
DAB adaptor protein 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DAB1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:123,154,360...124,279,170
Ensembl chr 5:123,905,166...124,280,115
|
|
G |
Dao |
D-amino-acid oxidase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DAO mRNA |
CTD |
PMID:25380136 |
|
NCBI chr12:48,353,691...48,373,647
Ensembl chr12:48,354,196...48,365,784
|
|
G |
Dap |
death-associated protein |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DAP mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:84,275,884...84,328,998
Ensembl chr 2:84,275,884...84,328,998
|
|
G |
Daxx |
death-domain associated protein |
multiple interactions increases expression |
ISO |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of DAXX mRNA] |
CTD |
PMID:15913567 |
|
NCBI chr20:5,480,103...5,485,962
Ensembl chr20:5,480,103...5,485,926
|
|
G |
Dbf4 |
DBF4 zinc finger |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DBF4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:22,898,527...22,914,091
Ensembl chr 4:22,898,527...22,914,177
|
|
G |
Dbndd2 |
dysbindin domain containing 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DBNDD2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:160,933,833...160,938,468
Ensembl chr 3:160,935,709...160,938,467
|
|
G |
Dcdc2c |
doublecortin domain containing 2C |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DCDC2C mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:47,737,814...47,812,219
Ensembl chr 6:47,774,060...47,848,075
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DCLK1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:144,646,255...144,939,389
Ensembl chr 2:144,646,308...144,936,927
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DCXR mRNA |
CTD |
PMID:25380136 |
|
NCBI chr10:109,906,119...109,909,696
Ensembl chr10:109,906,815...109,909,715
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression increases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DDC mRNA 1-Naphthylisothiocyanate results in increased expression of DDC mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
|
|
G |
Ddias |
DNA damage-induced apoptosis suppressor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DDIAS mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:157,675,754...157,700,064
Ensembl chr 1:157,675,765...157,700,064
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of DDIT3 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DDIT3 mRNA |
CTD |
PMID:17522070 PMID:27344345 |
|
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
|
|
G |
Decr2 |
2,4-dienoyl-CoA reductase 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DECR2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:15,451,850...15,460,227
Ensembl chr10:15,431,638...15,465,413
|
|
G |
Defb1 |
defensin beta 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DEFB1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:75,294,385...75,309,127
Ensembl chr16:75,294,376...75,309,176
|
|
G |
Depdc1 |
DEP domain containing 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DEPDC1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:264,704,738...264,738,265
Ensembl chr 2:264,704,769...264,738,257
|
|
G |
Depdc1b |
DEP domain containing 1B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DEPDC1B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:39,980,796...40,069,982
Ensembl chr 2:40,000,313...40,069,975
|
|
G |
Depdc7 |
DEP domain containing 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DEPDC7 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:94,665,714...94,687,013
Ensembl chr 3:94,665,717...94,686,989
|
|
G |
Depp1 |
DEPP1, autophagy regulator |
increases expression decreases expression |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of DEPP1 mRNA 1-Naphthylisothiocyanate results in decreased expression of DEPP1 mRNA |
CTD |
PMID:17175557 PMID:30723492 |
|
NCBI chr 4:148,780,330...148,784,566
Ensembl chr 4:148,782,479...148,784,562
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DHCR24 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:126,164,708...126,188,926
Ensembl chr 5:126,164,674...126,191,206
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
multiple interactions increases expression |
ISO EXP |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DHCR7 mRNA 1-Naphthylisothiocyanate results in increased expression of DHCR7 mRNA |
CTD |
PMID:27344345 PMID:30723492 |
|
NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DHRS3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DHRS7 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 6:95,522,577...95,541,393
Ensembl chr 6:95,522,577...95,541,393
|
|
G |
Dhrs7l1 |
dehydrogenase/reductase (SDR family) member 7-like 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DHRS7L1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:95,387,709...95,502,845
Ensembl chr 6:95,387,718...95,502,845
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DHRS9 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:55,623,671...55,645,883
Ensembl chr 3:55,623,634...55,648,325
|
|
G |
Dhtkd1 |
dehydrogenase E1 and transketolase domain containing 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DHTKD1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr17:76,306,585...76,358,058
Ensembl chr17:76,306,585...76,358,058
|
|
G |
Diaph3 |
diaphanous-related formin 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DIAPH3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:69,928,507...70,400,077
Ensembl chr15:70,039,424...70,399,924
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DIO1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 5:126,894,837...126,911,532
Ensembl chr 5:126,895,286...126,911,520
|
|
G |
Dipk2a |
divergent protein kinase domain 2A |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DIPK2A mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:102,140,713...102,159,828
Ensembl chr 8:102,088,505...102,159,828
|
|
G |
Disp1 |
dispatched RND transporter family member 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DISP1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:101,451,932...101,597,570
Ensembl chr13:101,451,932...101,597,570
|
|
G |
Disp2 |
dispatched RND transporter family member 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DISP2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:110,574,383...110,589,909
Ensembl chr 3:110,574,417...110,589,921
|
|
G |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DKK2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:237,148,918...237,240,883
Ensembl chr 2:237,148,941...237,241,350
|
|
G |
Dlgap1 |
DLG associated protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DLGAP1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:118,277,046...119,159,807
Ensembl chr 9:118,586,179...119,158,196
|
|
G |
Dlgap5 |
DLG associated protein 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DLGAP5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:24,167,484...24,199,417
Ensembl chr15:24,167,486...24,199,341
|
|
G |
Dlx4 |
distal-less homeobox 4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DLX4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:82,958,525...82,963,919
Ensembl chr10:82,958,525...82,963,919
|
|
G |
Dnaaf3 |
dynein, axonemal, assembly factor 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DNAAF3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:72,874,131...72,882,867
Ensembl chr 1:72,874,404...72,883,002
|
|
G |
Dnah8 |
dynein, axonemal, heavy chain 8 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DNAH8 mRNA |
CTD |
PMID:12832660 |
|
NCBI chr20:9,301,317...9,560,805
Ensembl chr20:9,313,271...9,560,682
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DNAJA1 mRNA |
CTD |
PMID:20551477 |
|
NCBI chr 5:57,028,467...57,039,378
Ensembl chr 5:57,028,467...57,039,378
|
|
G |
Dnaja4 |
DnaJ heat shock protein family (Hsp40) member A4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DNAJA4 mRNA |
CTD |
PMID:20551477 |
|
NCBI chr 8:59,278,262...59,294,003
Ensembl chr 8:59,278,262...59,294,003
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of DNAJB1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DNAJB1 mRNA |
CTD |
PMID:20551477 PMID:27344345 |
|
NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
|
|
G |
Dnajb12 |
DnaJ heat shock protein family (Hsp40) member B12 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DNAJB12 mRNA |
CTD |
PMID:20551477 |
|
NCBI chr20:29,445,510...29,463,739
Ensembl chr20:29,445,510...29,463,738
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DNAJB4 mRNA |
CTD |
PMID:20551477 |
|
NCBI chr 2:257,394,692...257,425,344
Ensembl chr 2:257,394,818...257,425,242
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DNAJB9 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
|
|
G |
Dnase1l2 |
deoxyribonuclease 1 like 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DNASE1L2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:13,812,335...13,814,514
Ensembl chr10:13,812,707...13,814,304
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
increases expression multiple interactions |
ISO |
1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA] |
CTD |
PMID:15913567 |
|
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
|
|
G |
Doc2a |
double C2 domain alpha |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DOC2A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:198,282,828...198,288,611
Ensembl chr 1:198,284,473...198,288,113
|
|
G |
Dpp7 |
dipeptidylpeptidase 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DPP7 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:2,569,135...2,573,387
Ensembl chr 3:2,569,135...2,573,387
|
|
G |
Dpys |
dihydropyrimidinase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DPYS mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:78,769,918...78,847,941
Ensembl chr 7:78,769,807...78,847,974
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DPYSL2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:43,475,640...43,581,725
Ensembl chr15:43,477,629...43,542,939
|
|
G |
Dram1 |
DNA-damage regulated autophagy modulator 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DRAM1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 7:28,898,647...28,932,641
Ensembl chr 7:28,898,649...28,932,641
|
|
G |
Dsg1 |
desmoglein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DSG1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:12,008,301...12,040,337
Ensembl chr18:12,008,759...12,038,053
|
|
G |
Dsn1 |
DSN1 component of MIS12 kinetochore complex |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DSN1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:153,101,020...153,115,326
Ensembl chr 3:153,101,036...153,114,520
|
|
G |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DSTYK mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:49,195,325...49,243,327
Ensembl chr13:49,195,325...49,243,316
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DTL mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:110,219,276...110,257,345
Ensembl chr13:110,220,283...110,257,367
|
|
G |
Duoxa2 |
dual oxidase maturation factor 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DUOXA2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:114,236,718...114,240,086
Ensembl chr 3:114,236,718...114,240,086
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DUSP10 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:104,284,660...104,321,455
Ensembl chr13:104,284,660...104,321,455
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DUSP16 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:168,470,141...168,551,346
Ensembl chr 4:168,472,412...168,517,177
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of DUSP6 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DUSP8 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:215,030,429...215,043,111
Ensembl chr 1:215,030,429...215,033,460
|
|
G |
Dysf |
dysferlin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of DYSF mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:115,700,942...115,901,873
Ensembl chr 4:115,712,850...115,901,873
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of E2F1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
|
|
G |
E2f7 |
E2F transcription factor 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of E2F7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:53,275,659...53,318,261
Ensembl chr 7:53,275,676...53,316,481
|
|
G |
E2f8 |
E2F transcription factor 8 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of E2F8 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:104,185,436...104,203,683
Ensembl chr 1:104,187,100...104,202,591
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of EBP mRNA |
CTD |
PMID:27344345 |
|
NCBI chr X:15,049,394...15,055,782
Ensembl chr X:15,049,462...15,055,781
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ECH1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:87,009,798...87,015,996
Ensembl chr 1:87,009,730...87,016,005
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ECM2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr17:15,533,760...15,566,403
Ensembl chr17:15,533,972...15,566,332
|
|
G |
Ect2 |
epithelial cell transforming 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ECT2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:112,769,385...112,831,476
Ensembl chr 2:112,769,385...112,831,476
|
|
G |
Ect2l |
epithelial cell transforming 2 like |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ECT2L mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:13,301,918...13,372,928
Ensembl chr 1:13,302,256...13,341,952
|
|
G |
Edar |
ectodysplasin-A receptor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EDAR mRNA |
CTD |
PMID:30723492 |
|
NCBI chr20:28,179,132...28,263,092
Ensembl chr20:28,179,140...28,263,037
|
|
G |
Efcab11 |
EF-hand calcium binding domain 11 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EFCAB11 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:123,742,971...123,894,714
Ensembl chr 6:123,743,064...123,894,826
|
|
G |
Efna5 |
ephrin A5 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EFNA5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:110,054,002...110,329,878
Ensembl chr 9:110,057,155...110,225,486
|
|
G |
Efs |
embryonal Fyn-associated substrate |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EFS mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:33,579,952...33,590,217
Ensembl chr15:33,578,381...33,589,522
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EGF mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:68,820,616...68,895,537
|
|
G |
Egfl6 |
EGF-like-domain, multiple 6 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EGFL6 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr X:29,430,789...29,488,737
Ensembl chr X:29,430,831...29,488,739
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EGLN3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions increases expression |
ISO EXP |
[FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of EGR1 mRNA; EGR1 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 protein]; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]] 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA; 1-Naphthylisothiocyanate results in increased expression of EGR1 protein Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] |
CTD |
PMID:15913567 PMID:18364083 PMID:18590720 PMID:20551477 PMID:21356363 PMID:22094456 PMID:27853831 |
|
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Egr4 |
early growth response 4 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EGR4 mRNA |
CTD |
PMID:12832660 |
|
NCBI chr 4:117,293,620...117,296,082
Ensembl chr 4:117,293,620...117,296,082
|
|
G |
Ehf |
ets homologous factor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EHF mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:93,176,257...93,216,484
Ensembl chr 3:93,178,163...93,216,495
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EHHADH mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364
|
|
G |
Eif4e3 |
eukaryotic translation initiation factor 4E family member 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EIF4E3 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:132,068,581...132,111,092
Ensembl chr 4:132,068,598...132,111,079
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ELAPOR1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:211,243,398...211,323,283
Ensembl chr 2:211,246,068...211,322,719
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ELF3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:52,083,873...52,088,798
Ensembl chr13:52,083,859...52,088,780
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ELOVL5 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:85,220,941...85,287,449
Ensembl chr 8:85,259,982...85,285,983
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ELOVL6 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145 Ensembl chr 2:234,189,105...234,296,145
|
|
G |
Elovl7 |
ELOVL fatty acid elongase 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ELOVL7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:40,373,211...40,386,643
Ensembl chr 2:40,373,211...40,386,669
|
|
G |
Emb |
embigin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EMB mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:49,682,763...49,733,475
Ensembl chr 2:49,682,754...49,732,253
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EME1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:82,366,820...82,375,510
Ensembl chr10:82,367,084...82,374,171
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EMP1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:169,161,076...169,181,967
Ensembl chr 4:169,147,243...169,181,966
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ENC1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
|
|
G |
Enpep |
glutamyl aminopeptidase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ENPEP mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:233,667,253...233,743,866
Ensembl chr 2:233,667,254...233,743,866
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPB41L2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:20,881,820...21,067,713
Ensembl chr 1:20,893,995...20,962,526
|
|
G |
Epcam |
epithelial cell adhesion molecule |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPCAM mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
|
|
G |
Epdr1 |
ependymin related 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPDR1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr17:47,397,558...47,422,183
Ensembl chr17:47,397,558...47,422,182
|
|
G |
Epha2 |
Eph receptor A2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPHA2 mRNA |
CTD |
PMID:20551477 |
|
NCBI chr 5:159,845,773...159,874,203
Ensembl chr 5:159,845,774...159,874,206
|
|
G |
Ephb3 |
Eph receptor B3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPHB3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:83,527,960...83,546,742
Ensembl chr11:83,527,962...83,546,674
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPHX1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
decreases activity |
ISO |
1-Naphthylisothiocyanate results in decreased activity of EPHX2 protein |
CTD |
PMID:3621371 |
|
NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
|
|
G |
Epn2 |
epsin 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPN2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:47,795,496...47,857,373
Ensembl chr10:47,795,524...47,857,326
|
|
G |
Eppk1 |
epiplakin 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EPPK1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:117,163,383...117,173,741
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ERCC6L mRNA |
CTD |
PMID:30723492 |
|
NCBI chr X:72,018,373...72,034,140
Ensembl chr X:72,018,373...72,034,099
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ERG28 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:109,683,252...109,692,218
Ensembl chr 6:109,683,253...109,692,218
|
|
G |
Eri2 |
ERI1 exoribonuclease family member 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of ERI2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:189,540,145...189,549,891
Ensembl chr 1:189,540,145...189,549,891
|
|
G |
Erich5 |
glutamate-rich 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ERICH5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:73,222,331...73,243,684
Ensembl chr 7:73,222,730...73,242,899
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ERN1 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ESCO2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:42,500,929...42,519,019
Ensembl chr15:42,500,929...42,518,855
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ESPL1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:143,896,890...143,923,868
Ensembl chr 7:143,897,014...143,923,868
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of ETS1 mRNA |
CTD |
PMID:12832660 |
|
NCBI chr 8:33,756,634...33,879,625
Ensembl chr 8:33,816,386...33,879,625
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EXO1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:93,936,989...93,962,749
Ensembl chr13:93,939,022...93,960,342
|
|
G |
Exph5 |
exophilin 5 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EXPH5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:57,885,932...57,962,574
Ensembl chr 8:57,886,168...57,962,708
|
|
G |
Extl1 |
exostosin-like glycosyltransferase 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of EXTL1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 5:152,573,755...152,588,956
Ensembl chr 5:152,573,758...152,589,719
|
|
G |
Ezr |
ezrin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of EZR mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
|
|
G |
F11r |
F11 receptor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of F11R mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:89,826,272...89,850,151
Ensembl chr13:89,826,254...89,850,612
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
affects response to substance |
ISO |
F13A1 protein affects the susceptibility to 1-Naphthylisothiocyanate |
CTD |
PMID:26921287 |
|
NCBI chr17:28,504,650...28,680,015
Ensembl chr17:28,504,623...28,680,362
|
|
G |
F2 |
coagulation factor II |
increases expression multiple interactions |
ISO |
1-Naphthylisothiocyanate results in increased expression of F2 protein 1-Naphthylisothiocyanate results in increased expression of and results in increased activity of F2 protein; F3 mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein]; F3 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein] |
CTD |
PMID:21070799 PMID:24633426 |
|
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
multiple interactions increases expression |
ISO EXP |
F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] 1-Naphthylisothiocyanate results in increased expression of F2R mRNA F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:21037076 PMID:25380136 |
|
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of F2RL1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:25,222,324...25,235,275
Ensembl chr 2:25,222,328...25,235,275
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
increases response to substance |
ISO |
F2RL3 gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate |
CTD |
PMID:27475285 |
|
NCBI chr16:18,817,797...18,819,790
Ensembl chr16:18,814,622...18,819,833
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases activity increases expression multiple interactions increases response to substance |
ISO |
1-Naphthylisothiocyanate results in increased activity of F3 protein 1-Naphthylisothiocyanate results in increased expression of F3 mRNA F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] F3 mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; F3 mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein]; F3 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein] F3 protein results in increased susceptibility to 1-Naphthylisothiocyanate |
CTD |
PMID:21037076 PMID:21070799 |
|
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
F5 |
coagulation factor V |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of F5 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534
|
|
G |
Faap20 |
FA core complex associated protein 20 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAAP20 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:172,648,171...172,655,576
Ensembl chr 5:172,648,950...172,655,576
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FABP1 mRNA |
CTD |
PMID:17522070 PMID:30723492 |
|
NCBI chr 4:99,063,181...99,066,957
Ensembl chr 4:99,063,181...99,066,954
|
|
G |
Fabp12 |
fatty acid binding protein 12 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FABP12 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:93,712,468...93,766,665
Ensembl chr 2:93,712,992...93,766,670
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FABP2 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr 2:227,080,912...227,083,654
Ensembl chr 2:227,080,924...227,083,501
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FABP4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FABP5 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:93,981,662...93,985,322
Ensembl chr 2:93,981,656...93,985,378
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FABP7 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr20:40,769,624...40,773,156
Ensembl chr20:40,769,586...40,773,349
|
|
G |
Fads1 |
fatty acid desaturase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FADS1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:226,234,034...226,249,118
Ensembl chr 1:226,234,074...226,249,138
|
|
G |
Fads2 |
fatty acid desaturase 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FADS2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:225,906,582...226,152,568
Ensembl chr 1:226,114,413...226,152,524
|
|
G |
Fads3 |
fatty acid desaturase 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FADS3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:226,091,774...226,108,332
Ensembl chr 1:226,091,774...226,108,332
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FAHD1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr10:14,214,518...14,215,957
Ensembl chr10:14,214,519...14,215,957
|
|
G |
Fam102b |
family with sequence similarity 102, member B |
affects expression |
EXP |
1-Naphthylisothiocyanate affects the expression of FAM102B mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:211,762,479...211,831,837
Ensembl chr 2:211,772,128...211,831,636
|
|
G |
Fam131b |
family with sequence similarity 131, member B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAM131B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:71,703,872...71,713,268
Ensembl chr 4:71,703,873...71,713,063
|
|
G |
Fam214a |
family with sequence similarity 214, member A |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FAM214A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:81,863,619...81,941,548
Ensembl chr 8:81,863,619...81,941,536
|
|
G |
Fam25a |
family with sequence similarity 25, member A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAM25A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:10,702,264...10,706,073
Ensembl chr16:10,702,263...10,706,073
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAM43A mRNA |
CTD |
PMID:25380136 |
|
NCBI chr11:73,676,601...73,679,003
Ensembl chr11:73,676,601...73,678,984
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAM83D mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:155,269,344...155,288,612
Ensembl chr 3:155,269,347...155,288,533
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAM89A mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr19:57,502,308...57,514,896
Ensembl chr19:57,502,308...57,514,896
|
|
G |
Fancd2 |
FA complementation group D2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FANCD2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:145,489,869...145,551,479
Ensembl chr 4:145,489,869...145,551,479
|
|
G |
Fanci |
FA complementation group I |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FANCI mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:141,116,565...141,172,997
Ensembl chr 1:141,120,166...141,172,483
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAS mRNA |
CTD |
PMID:14623915 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions increases expression |
ISO EXP |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FASN mRNA 1-Naphthylisothiocyanate results in increased expression of FASN mRNA |
CTD |
PMID:27344345 PMID:30723492 |
|
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FAT1 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr16:50,372,150...50,501,716
Ensembl chr16:50,372,128...50,501,921
|
|
G |
Fblim1 |
filamin binding LIM protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FBLIM1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:160,122,466...160,158,921
Ensembl chr 5:160,122,425...160,158,386
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FBLN1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:126,096,793...126,176,468
Ensembl chr 7:126,096,793...126,176,468
|
|
G |
Fbn1 |
fibrillin 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FBN1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FBN2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:53,068,495...53,272,254
Ensembl chr18:53,068,495...53,181,503
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FBP1 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr17:396,175...417,480
Ensembl chr17:396,180...417,480
|
|
G |
Fbxl7 |
F-box and leucine-rich repeat protein 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FBXL7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:79,067,907...79,439,987
Ensembl chr 2:79,067,915...79,078,258
|
|
G |
Fbxo9 |
f-box protein 9 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FBXO9 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:85,388,331...85,413,896
Ensembl chr 8:85,388,333...85,413,484
|
|
G |
Fcer1g |
Fc fragment of IgE receptor Ig |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FCER1G mRNA |
CTD |
PMID:25380136 |
|
NCBI chr13:89,601,894...89,606,326
Ensembl chr13:89,601,896...89,606,326
|
|
G |
Fcer2 |
Fc fragment of IgE receptor II |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FCER2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr12:2,233,772...2,245,324
Ensembl chr12:2,233,778...2,245,324
|
|
G |
Fcgr1a |
Fc fragment of IgG receptor Ia |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FCGR1A mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:198,430,536...198,439,453
Ensembl chr 2:198,430,530...198,458,041
|
|
G |
Fcmr |
Fc fragment of IgM receptor |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FCMR mRNA |
CTD |
PMID:30723492 |
|
NCBI chr13:47,602,701...47,617,065
Ensembl chr13:47,602,692...47,617,064
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FDFT1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
|
|
G |
Fdps |
farnesyl diphosphate synthase |
multiple interactions increases expression |
ISO EXP |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FDPS mRNA 1-Naphthylisothiocyanate results in increased expression of FDPS mRNA |
CTD |
PMID:27344345 PMID:30723492 |
|
NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
|
|
G |
Fdx1 |
ferredoxin 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FDX1 mRNA |
CTD |
PMID:12832660 |
|
NCBI chr 8:56,373,729...56,393,199
Ensembl chr 8:56,373,723...56,393,233
|
|
G |
Fermt1 |
fermitin family member 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FERMT1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:125,566,744...125,607,864
Ensembl chr 3:125,566,643...125,607,735
|
|
G |
Fetub |
fetuin B |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FETUB mRNA |
CTD |
PMID:27344345 |
|
NCBI chr11:81,648,890...81,660,472
Ensembl chr11:81,648,885...81,660,395
|
|
G |
Fga |
fibrinogen alpha chain |
increases expression multiple interactions increases response to substance affects response to substance |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of FGA mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FGA mRNA [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CCL2 mRNA; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL1 mRNA; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL2 mRNA; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of EGR1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of FGA mRNA FGA protein affects the susceptibility to 1-Naphthylisothiocyanate |
CTD |
PMID:17522070 PMID:20974703 PMID:21356363 PMID:27344345 PMID:30352267 |
|
NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
|
|
G |
Fgb |
fibrinogen beta chain |
increases expression |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of FGB mRNA |
CTD |
PMID:17522070 PMID:20974703 PMID:26921287 |
|
NCBI chr 2:182,028,044...182,035,026
Ensembl chr 2:182,027,115...182,038,178
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FGF1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Fgf11 |
fibroblast growth factor 11 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FGF11 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:56,403,320...56,410,816
Ensembl chr10:56,403,256...56,409,017
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
increases expression multiple interactions |
ISO |
1-Naphthylisothiocyanate results in increased expression of FGF15 mRNA alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FGF15 mRNA] |
CTD |
PMID:25655198 |
|
NCBI chr 1:218,058,405...218,061,693
Ensembl chr 1:218,058,405...218,061,693
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FGF2 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FGF23 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:159,622,404...159,630,082
Ensembl chr 4:159,622,404...159,630,082
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FGF7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:118,315,859...118,368,464
Ensembl chr 3:118,317,761...118,366,872
|
|
G |
Fgg |
fibrinogen gamma chain |
increases expression affects expression affects response to substance multiple interactions |
ISO |
1-Naphthylisothiocyanate results in increased expression of FGG mRNA 1-Naphthylisothiocyanate affects the expression of FGG mRNA FGG protein affects the susceptibility to 1-Naphthylisothiocyanate [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of FGG mRNA; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB1 mRNA]]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]] |
CTD |
PMID:20974703 PMID:26921287 PMID:30352267 |
|
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fgl2 |
fibrinogen-like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FGL2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 4:10,323,598...10,329,241
Ensembl chr 4:10,323,607...10,329,241
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FGR mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 5:151,172,189...151,199,746
Ensembl chr 5:151,172,206...151,199,745
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FHL1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr X:159,112,516...159,172,528
Ensembl chr X:159,112,880...159,172,524
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FHL2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
|
|
G |
Fignl1 |
fidgetin-like 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FIGNL1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr14:91,895,902...91,904,474
Ensembl chr14:91,895,909...91,904,433
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FKBP1A mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:147,042,944...147,062,725
Ensembl chr 3:147,042,944...147,062,724
|
|
G |
Flna |
filamin A |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FLNA mRNA |
CTD |
PMID:25380136 |
|
NCBI chr X:156,460,785...156,487,245
Ensembl chr X:156,463,953...156,487,245
|
|
G |
Flnc |
filamin C |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FLNC mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:56,710,934...56,738,779
Ensembl chr 4:56,711,049...56,738,791
|
|
G |
Flywch2 |
FLYWCH family member 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FLYWCH2 mRNA |
CTD |
PMID:30723492 |
|
|
|
G |
Fmnl2 |
formin-like 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FMNL2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:38,400,409...38,677,637
Ensembl chr 3:38,559,914...38,675,878
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
decreases expression |
ISO EXP |
1-Naphthylisothiocyanate results in decreased expression of FMO1 mRNA |
CTD |
PMID:15913567 PMID:17522070 PMID:25380136 PMID:30723492 |
|
NCBI chr13:80,712,885...80,745,095
Ensembl chr13:80,712,882...80,745,347
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
increases expression |
ISO |
1-Naphthylisothiocyanate results in increased expression of FMO3 mRNA; 1-Naphthylisothiocyanate results in increased expression of FMO3 protein |
CTD |
PMID:25193093 |
|
NCBI chr13:80,837,418...80,856,214
Ensembl chr13:80,837,420...80,862,963
|
|
G |
Folr2 |
folate receptor beta |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FOLR2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:166,915,045...166,933,377
Ensembl chr 1:166,915,045...166,919,302
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions affects expression increases expression |
ISO EXP |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOS mRNA] 1-Naphthylisothiocyanate affects the expression of FOS mRNA |
CTD |
PMID:15913567 PMID:25380136 PMID:30352267 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Foxa2 |
forkhead box A2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FOXA2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 3:142,383,084...142,387,493
Ensembl chr 3:142,383,278...142,387,481
|
|
G |
Foxm1 |
forkhead box M1 |
increases expression multiple interactions |
ISO EXP |
1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA; 1-Naphthylisothiocyanate results in increased expression of FOXM1 protein NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein] |
CTD |
PMID:29660435 PMID:30723492 |
|
NCBI chr 4:161,685,236...161,697,633
Ensembl chr 4:161,685,258...161,696,305
|
|
G |
Foxn3 |
forkhead box N3 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FOXN3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:123,183,720...123,577,719
Ensembl chr 6:123,187,726...123,577,695
|
|
G |
Foxp3 |
forkhead box P3 |
affects expression decreases expression |
ISO EXP |
1-Naphthylisothiocyanate affects the expression of FOXP3 mRNA 1-Naphthylisothiocyanate results in decreased expression of FOXP3 mRNA |
CTD |
PMID:20594950 PMID:30723492 |
|
NCBI chr X:15,753,175...15,768,648
Ensembl chr X:15,753,175...15,768,522
|
|
G |
Frem2 |
FRAS1 related extracellular matrix 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FREM2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:142,747,501...142,885,604
Ensembl chr 2:142,747,501...142,885,604
|
|
G |
Fsip1 |
fibrous sheath interacting protein 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FSIP1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 3:109,877,943...110,021,186
Ensembl chr 3:109,969,152...110,021,149
|
|
G |
Fst |
follistatin |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FST mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457
|
|
G |
Fstl1 |
follistatin-like 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FSTL1 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr11:65,791,196...65,845,721
Ensembl chr11:65,782,567...65,845,418
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FSTL3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:12,806,031...12,810,556
Ensembl chr 7:12,804,919...12,810,570
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FTCD mRNA |
CTD |
PMID:25380136 |
|
NCBI chr20:12,806,957...12,820,466
Ensembl chr20:12,806,957...12,820,466
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
ISO |
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FTH1 mRNA |
CTD |
PMID:27344345 |
|
NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
|
|
G |
Fut2 |
fucosyltransferase 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FUT2 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 1:101,631,633...101,651,668
Ensembl chr 1:101,631,635...101,651,668
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FXYD2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:49,710,334...49,717,492
Ensembl chr 8:49,710,477...49,716,955
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FXYD5 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 1:89,464,853...89,474,450
Ensembl chr 1:89,464,860...89,474,252
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of FXYD6 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 8:49,676,520...49,703,419
Ensembl chr 8:49,676,540...49,703,419
|
|
G |
Fzd1 |
frizzled class receptor 1 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FZD1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:26,470,864...26,475,262
Ensembl chr 4:26,470,864...26,475,262
|
|
G |
Fzd7 |
frizzled class receptor 7 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FZD7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 9:66,305,731...66,308,550
Ensembl chr 9:66,305,731...66,308,550
|
|
G |
Fzd8 |
frizzled class receptor 8 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of FZD8 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr17:62,259,910...62,267,239
Ensembl chr17:62,262,129...62,265,113
|
|
G |
G0s2 |
G0/G1switch 2 |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of G0S2 mRNA |
CTD |
PMID:25380136 PMID:30723492 |
|
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
increases expression decreases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of G6PC1 mRNA 1-Naphthylisothiocyanate results in decreased expression of G6PC1 mRNA |
CTD |
PMID:18289764 PMID:25380136 PMID:30723492 |
|
NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression multiple interactions |
EXP ISO |
1-Naphthylisothiocyanate results in increased expression of GADD45A mRNA Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GADD45A mRNA] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GADD45A mRNA |
CTD |
PMID:17522070 PMID:27344345 PMID:30517764 PMID:30723492 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of GAL3ST1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr14:84,231,473...84,247,371
Ensembl chr14:84,231,639...84,247,369
|
|
G |
Galc |
galactosylceramidase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of GALC mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 6:122,177,195...122,239,411
Ensembl chr 6:122,178,602...122,239,614
|
|
G |
Gale |
UDP-galactose-4-epimerase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of GALE mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
|
|
G |
Gars |
glycyl-tRNA synthetase |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of GARS mRNA |
CTD |
PMID:20551477 |
|
NCBI chr 4:85,235,122...85,276,085
Ensembl chr 4:85,235,172...85,276,044
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of GAS2L3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:29,963,129...29,996,021
Ensembl chr 7:29,959,597...29,986,163
|
|
G |
Gask1a |
golgi associated kinase 1A |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of GASK1A mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:130,581,072...130,614,118
Ensembl chr 8:130,581,062...130,612,510
|
|
G |
Gask1b |
golgi associated kinase 1B |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of GASK1B mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:178,678,946...178,751,459
Ensembl chr 2:178,679,041...178,750,668
|
|
G |
Gata3 |
GATA binding protein 3 |
affects expression decreases expression |
ISO EXP |
1-Naphthylisothiocyanate affects the expression of GATA3 mRNA 1-Naphthylisothiocyanate results in decreased expression of GATA3 mRNA |
CTD |
PMID:20594950 PMID:30723492 |
|
NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
|
|
G |
Gatb |
glutamyl-tRNA amidotransferase subunit B |
decreases expression |
EXP |
1-Naphthylisothiocyanate results in decreased expression of GATB mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:184,600,695...184,679,980
Ensembl chr 2:184,600,721...184,679,683
|
|
G |
Gbp2 |
guanylate binding protein 2 |
increases expression |
EXP |
1-Naphthylisothiocyanate results in increased expression of GBP2 mRNA |
CTD |
PMID:25380136 |
|
NCBI chr 2:248,276,795...248,293,784
Ensembl chr 2:248,276,709...248,293,784
|
| |